131 – 140 of 221
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
-
Mark
Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33
(
- Contribution to journal › Article
-
Mark
IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
(
- Contribution to journal › Article
-
Mark
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation.
(
- Contribution to journal › Article
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review
-
Mark
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
(
- Contribution to journal › Article
-
Mark
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
(
- Contribution to journal › Article
-
Mark
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
(
- Contribution to journal › Article
-
Mark
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
(
- Contribution to journal › Article
-
Mark
Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control
(
- Contribution to journal › Article